Mobile consumer ECG maker AliveCor announced today that its long-teased six-lead ECG device has been cleared by the FDA and will be available to customers in June of this year.
“[The KardiaMobile 6L clearance] is a big deal for us, and it’s important for patients and physicians because they will be able to get a materially improved view into patients’ hearts,” Dr. Jacqueline Shreibati, chief medical officer at AliveCor, told MobiHealthNews. “It allows visibility into certain arrhythmias that was never available to consumers until now.”
The American Medical Association has always had an interesting relationship with digital health, vacillating between gadfly and cheerleader as it seeks to fulfill its role as the voice of physicians in industry conversations.
At the Cleveland Clinic Patient Experience: Empathy and Innovation Summit, an event held in Cleveland this week and organized in conjunction with HIMSS, AMA Board Chair Dr. Jack Resneck Jr. laid out the AMA’s perspective on the tremendous potential of digital health technology — as well as the many ways that potential is not being fulfilled.